AstraZeneca PLC ( AZN ) and Bristol-Myers Squibb Co. ( BMY ) have recalled about 92,000 vials of their jointly marketed Type 2 diabetes treatment Bydureon in several European countries because some vials weren't fully filled with the long- acting medication. The affected batches were recalled in the U.K., Germany, Romania, the Netherlands, Ireland, Sweden, Finland and Spain, said a Bristol-Myers spokesman. No batches distributed in other markets were affected and the companies don't expect any supply issues, he said.